cystine has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevet, E; Fernandez-Zapico, ME; Higa, A; Jensen, D; Lhomond, S; Pasquet, JM; Schekman, R; Simpson, JC; Taouji, S | 1 |
| Adam, T; Faber, E; Friedecký, D; Karlíková, R; Mičová, K; Najdekr, L; Vrobel, I | 1 |
2 other study(ies) available for cystine and imatinib mesylate
| Article | Year |
|---|---|
Endoplasmic reticulum stress-activated transcription factor ATF6α requires the disulfide isomerase PDIA5 to modulate chemoresistance.
Topics: Activating Transcription Factor 6; Antineoplastic Agents; Benzamides; Cell Survival; COP-Coated Vesicles; Cystine; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; HeLa Cells; Humans; Imatinib Mesylate; Piperazines; Protein Disulfide-Isomerases; Protein Transport; Pyrimidines; Unfolded Protein Response | 2014 |
Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis.
Topics: Antineoplastic Agents; Chromatography, Liquid; Cysteine; Cystine; Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Sulfur; Tandem Mass Spectrometry | 2017 |